Following U.S. Stocks were among the “Top Losers” during Friday’s trade: KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), PDL BioPharma Inc (NASDAQ:PDLI), Healthcare Trust Of America Inc (NYSE:HTA), Vivint Solar Inc(NYSE:VSLR)
Their insights are depicted underneath:
KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)’s dipped -5.80%. With recent incline, the year-to-date (YTD) performance reflected a -62.43% decline below last year. During the past month the stock gains 54.84%, bringing three-month performance to -65.61% and six-month performance to -59.37%.
KaloBios Pharmaceuticals, Inc., a biopharmaceutical corporation, primarily develops monoclonal antibody therapeutics for the treatment of respiratory diseases and cancer in the United States.
PDL BioPharma Inc (NASDAQ:PDLI)’s shares dwindled -5.63%, and closed at $6.70.
According to PRNewswire, PDL BioPharma, Inc. (PDLI), declared that the adjusted conversion rate for the:
- 75% Convertible Senior Notes due May 1, 2015 (May 2015 Notes), is 174.8506 shares of ordinary stock per $1,000 principal amount or about $5.72 per share, effective March 3, 2015.
The conversion rate for the note is adjusted in connection with the regular quarterly dividend of $0.15 to be paid on March 12, 2015, to all stockholders who own shares of PDL on March 5, 2015, the record date.
May 2015 Notes:
The conversion rate for the May 2015 Notes was formerly 171.1768 shares of ordinary stock per $1,000 principal amount of the May 2015 Notes. In connection with a cash dividend, the conversion rate is raised by multiplying the previous conversion rate by a fraction, the numerator of which is the average closing price of PDL’s ordinary stock for the 10 successive trading days right away preceding the ex-dividend date of March 3, 2015, for the cash dividend, and the denominator of which is such average closing price minus the per share dividend amount.
PDL manages a portfolio of patents and royalty assets, comprising of its Queen et al. patents, license contracts with various biotechnology and pharmaceutical companies, and royalty and other assets attained.
Healthcare Trust Of America Inc (NYSE:HTA), dropped -5.60%, and closed at $25.77. The company has the market capitalization of $3.23B. On the other hand the stock’s volatility for the week is 2.43%, and for the month is 2.26%. The stock price to book value is $2.22, however price to sale value is $8.68. Analyst’s mean recommendation regarding this stock is 2.70. (where 1=Buy, 5=Sale).
Healthcare Trust of America, Inc., a publicly traded real estate investment trust, is a real estate corporation that attains, owns, and operates medical office buildings located primarily on-campus or associated with the nation’s leading healthcare systems. HTA is known for its exclusive dedication to the medical office sector and believes that this focus will be advantageous to the extent the healthcare sector benefits from major macroeconomic tailwinds.
Vivint Solar Inc (NYSE:VSLR) declined -5.55%, and closed at $10.72.
According to PRNewswire, Vivint Solar, Inc. (VSLR), declared financial results for the fourth quarter and year ended December 31, 2014.
Fourth Quarter 2014 Operating Highlights:
Key operating and development highlights for the quarter ended December 31, 2014 comprise:
- MW Booked of about 52 MWs for the quarter, up about 150% year-over-year.
- MW Installed of about 50 MWs, up 191% year-over-year. Total cumulative MWs installed were about 228 MWs as of December 31, 2014.
- Installations were 6,864 for the quarter, up 135% year-over-year. Cumulative installations were 35,720 as of December 31, 2014.
- Estimated Nominal Contracted Payments Remaining raised by about $188 million during the quarter and was about $1,031 million at December 31, 2014, up 161% year-over-year.
- Estimated Retained Value raised by about $82 million during the quarter to about $481 million at December 31, 2014, up 153% contrast to the fourth quarter of 2013.
- Estimated Retained Value per Watt was $2.11 as of December 31, 2014.
On March 3, 2015, Vivint Solar reached a working capital facility with a capacity of $131 million. In addition, during the quarter and subsequent to quarter end, the corporation closed two new tax equity partnerships with existing tax equity partners. In total, we estimate the two funds will enable us to install about 66 MWs of solar energy systems.
Vivint Solar is a leading provider of distributed solar energy systems – electricity generated by a solar energy system installed at a customer’s location – to residential customers in the United States. Vivint Solar’s customers pay little to no money upfront, receive noteworthy savings relative to utility generated electricity rates and continue to benefit from guaranteed energy prices over the 20-year term of their contracts.
